Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS

[Farooqji]

Levodopa–carbidopa intestinal gel may provide sustained, long-term symptom control, while potentially avoiding increases in add-on medication dosages - the conclusions from the 5-yr follow-up of the COSMOS study, by Dr Alfonso Fasano & colleagues

link.springer.com/article/1...